NHL Cyberfamily

Non-Hodgkin's lymphoma support

 

Non-Hodgkin's lymphoma library

 

Lymphoma Research Library

In this section we will try to present you with the latest research about non-Hodgkin's lymphoma. We don't focus on any one type, but just present to you a variety of research on many fascinating up to date topics. This is the place for those who like to read detailed information.

Contents


Chapter 1 ASH abstracts

Each year the American Society of Hematology (ASH) holds a convention where the world's leading haematologists present the results of their work. Over 20,000 clinicians and scientists attend. The abstracts that they publish represent the latest treatments, scientific breakthroughs and innovations in treating lymphoma, leukaemia, and myeloma.

There are nearly 6,000 abstracts presented each year. We compile list of about 600 selected NHL abstracts from each years presentations that we felt are important enough for patients and caregivers to browse. This list is hyperlinked and contains only the title of the abstract, so it is easy to search. When you find one that interests you just click on it, and that will take you to the full text of the abstract.

To access each item simply click on the book beside it.

 

2016 ASH compilation of NHL abstracts ASH

2015 ASH compilation of NHL abstracts

ASH

2014 ASH compilation of NHL abstracts

ASH

2013 ASH compilation of NHL abstracts

ASH
   

 


Chapter 2 ASH Education series

Similar to the ASH abstracts, each year the American Society for Haematologists publishes a series of articles that give an in-depth discussion of subjects of particular importance.

To access each item simply click on the book beside it.

2014

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC ASH education series
Impact of MYC on malignant behavior ASH education series
Double-hit lymphomas: current paradigms and novel treatment approaches ASH education series
Indolent lymphoma: follicular lymphoma and the microenvironment—insights from the microscope ASH education series
Indolent lymphoma: follicular lymphoma and the microenvironment—insights from gene expression profiling ASH education series
Therapeutic targeting of microenvironment in follicular lymphoma ASH education series
Optimal disease surveillance strategies in non-Hodgkin lymphoma ASH education series
Caring for the long-term survivor after allogeneic stem cell transplantation ASH education series
Cytotoxic T lymphocytes for leukemia and lymphoma ASH education series
Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions ASH education series

2013

Targeting B-cell receptor signaling: changing the paradigm ASH education series
Dissecting follicular lymphoma: high versus low risk ASH education series
Transplantation for mantle cell lymphoma: is it the right thing to do?  ASH education series
Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification  ASH education series
Treatment strategies for aggressive lymphomas: what works? ASH education series
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP ASH education series

2012

Interim PET-CT in the management of diffuse large B-cell lymphoma ASH education series
Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma  ASH education series
Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma? ASH education series
Changing role of stem cell transplantation in follicular lymphoma ASH education series
The many faces of marginal zone lymphoma  ASH education series
Is there a role for “watch and wait” in follicular lymphoma in the rituximab era? ASH education series

2011

Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies ASH education series
B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas ASH education series
Tricky and Terrible T-Cell Tumors: These are Thrilling Times for Testing: Molecular Pathology of Peripheral T-Cell Lymphomas ASH education series
Relapsed/Refractory Diffuse Large B-Cell Lymphoma ASH education series
Therapies for Peripheral T-Cell Lymphomas ASH education series

2010

Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation ASH education series
Comorbidities and Hematopoietic Cell Transplantation Outcomes ASH education series
Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation ASH education series
Host Factors for Risk and Survival in Lymphoma ASH education series
Novel Agents for Follicular Lymphoma ASH education series

2009

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research ASH education series 
The incidence, natural history, biology, and treatment of transformed lymphomas ASH education series 
Current treatment standards and emerging strategies in mantle cell lymphoma  ASH education series 

2008

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL ASH education series 
Primary Mediastinal B-Cell Lymphoma ASH education series 
Burkitt Lymphoma in Adults ASH education series 
Novel Therapies and Role of Transplant in the Treatment of Peripheral T-Cell Lymphomas ASH education series 
Prognosis and Primary Therapy in Peripheral T-Cell Lymphomas ASH education series 
Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas ASH education series 
Recognizing and Managing Chronic Graft-Versus-Host Disease ASH education series 
Old and New Cancers after Hematopoietic-Cell Transplantation ASH education series 
Does High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation Have a Role in the Primary Treatment of Peripheral T-Cell Lymphomas? ASH education series 


website
statistics